Literature DB >> 34261097

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.

Jake A Ruddy1, Brian J Boyarsky, Justin R Bailey, Andrew H Karaba, Jacqueline M Garonzik-Wang, Dorry L Segev, Christine M Durand, William A Werbel.   

Abstract

This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain antibody titers after two doses, despite varied titers after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.
Copyright © 2021 Wolters Kluwer Health, Inc.

Entities:  

Year:  2021        PMID： 34261097     DOI： 10.1097/QAD.0000000000003017

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  29 in total

1.  Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity.

Authors:  Elena Morrocchi; Chiara Pighi; Giuseppe Rubens Pascucci; Nicola Cotugno; Chiara Medri; Donato Amodio; Luna Colagrossi; Alessandra Ruggiero; Emma Concetta Manno; Chiara Casamento Tumeo; Stefania Bernardi; Kinga K Smolen; Carlo Federico Perno; Al Ozonoff; Paolo Rossi; Ofer Levy; Paolo Palma
Journal:  Clin Infect Dis       Date:  2022-08-15       Impact factor: 20.999

2.  COVID-19 Telemedicine and Vaccination at an Urban Safety Net HIV Medicine Clinic.

Authors:  Ryan Anson; Aaron Willcott; Will Toperoff; Afsana Karim; Michael Tang; Darcy Wooten; J Tyler Lonergan; Laura Bamford
Journal:  J Nurse Pract       Date:  2022-07-12       Impact factor: 0.826

3.  Humoral Immune Response to Inactivated COVID-19 Vaccination at the 3rd Month among People Living with HIV.

Authors:  Songjie Wu; Shi Zou; Fangzhao Ming; Mengmeng Wu; Wei Guo; Zhongyuan Xing; Zhiyue Zhang; Jinli Liu; Weiming Tang; Ke Liang
Journal:  Res Sq       Date:  2022-06-27

4.  Never say "never the twain shall meet": Combining antiretroviral therapy and RNA vaccine to obtain an adequate humoral immune response in people living with HIV.

Authors:  Jean-Pierre Routy; Stéphane Isnard
Journal:  Lancet Reg Health Eur       Date:  2022-01-25

5.  Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy.

Authors:  Zabrina L Brumme; Francis Mwimanzi; Hope R Lapointe; Peter Cheung; Yurou Sang; Maggie C Duncan; Fatima Yaseen; Olga Agafitei; Siobhan Ennis; Kurtis Ng; Simran Basra; Li Yi Lim; Rebecca Kalikawe; Sarah Speckmaier; Nadia Moran-Garcia; Landon Young; Hesham Ali; Bruce Ganase; Gisele Umviligihozo; F Harrison Omondi; Kieran Atkinson; Hanwei Sudderuddin; Junine Toy; Paul Sereda; Laura Burns; Cecilia T Costiniuk; Curtis Cooper; Aslam H Anis; Victor Leung; Daniel Holmes; Mari L DeMarco; Janet Simons; Malcolm Hedgcock; Marc G Romney; Rolando Barrios; Silvia Guillemi; Chanson J Brumme; Ralph Pantophlet; Julio S G Montaner; Masahiro Niikura; Marianne Harris; Mark Hull; Mark A Brockman
Journal:  medRxiv       Date:  2021-10-15

Review 6.  Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions.

Authors:  Michael J Peluso; Joanna Donatelli; Timothy J Henrich
Journal:  Transl Res       Date:  2021-11-12       Impact factor: 7.012

7.  Adverse events of inactivated COVID-19 vaccine in HIV-infected adults.

Authors:  Songjie Wu; Yubin Zhang; Fangzhao Ming; Shi Zou; Mengmeng Wu; Wei Guo; Weiming Tang; Ke Liang
Journal:  AIDS Res Ther       Date:  2021-12-04       Impact factor: 2.250

8.  Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV).

Authors:  Khadija Khan; Gila Lustig; Mallory Bernstein; Derseree Archary; Sandile Cele; Farina Karim; Muneerah Smith; Yashica Ganga; Zesuliwe Jule; Kajal Reedoy; Yoliswa Miya; Ntombifuthi Mthabela; Nombulelo P Magula; Richard Lessells; Tulio de Oliveira; Bernadett I Gosnell; Salim Abdool Karim; Nigel Garrett; Willem Hanekom; Linda-Gail Bekker; Glenda Gray; Jonathan M Blackburn; Mahomed-Yunus S Moosa; Alex Sigal
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

9.  Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy.

Authors:  Zabrina L Brumme; Francis Mwimanzi; Hope R Lapointe; Peter K Cheung; Yurou Sang; Maggie C Duncan; Fatima Yaseen; Olga Agafitei; Siobhan Ennis; Kurtis Ng; Simran Basra; Li Yi Lim; Rebecca Kalikawe; Sarah Speckmaier; Nadia Moran-Garcia; Landon Young; Hesham Ali; Bruce Ganase; Gisele Umviligihozo; F Harrison Omondi; Kieran Atkinson; Hanwei Sudderuddin; Junine Toy; Paul Sereda; Laura Burns; Cecilia T Costiniuk; Curtis Cooper; Aslam H Anis; Victor Leung; Daniel Holmes; Mari L DeMarco; Janet Simons; Malcolm Hedgcock; Marc G Romney; Rolando Barrios; Silvia Guillemi; Chanson J Brumme; Ralph Pantophlet; Julio S G Montaner; Masahiro Niikura; Marianne Harris; Mark Hull; Mark A Brockman
Journal:  NPJ Vaccines       Date:  2022-02-28       Impact factor: 9.399

Review 10.  Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection.

Authors:  Yulia Alexandrova; Cecilia T Costiniuk; Mohammad-Ali Jenabian
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.